* ” Believes it has sufficient financial resources to funds
operations into Q4 of 2017″
Source text for Eikon:
Further company coverage:
The post BRIEF-Corbus Pharmaceuticals reports Q2 loss per share $0.11 appeared first on NASDAQ.
Forex – financial instrument.Forex news
* ” Believes it has sufficient financial resources to funds
operations into Q4 of 2017″
Source text for Eikon:
Further company coverage:
The post BRIEF-Corbus Pharmaceuticals reports Q2 loss per share $0.11 appeared first on NASDAQ.